MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

AVNS — Avanos Medical, Inc.

NYSE

Avanos Medical, Inc.

Back to Screener
$24.99
+0.01(+0.04%)
O
24.98
H
25.00
L
24.98
V
2.08M
⏱️ End-of-day dataAs of Jul 24, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

AVNS Statistics

Total Valuation

Market Capn/a
Enterprise Valuen/a

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstandingn/a
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio227.18
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

Current Ratio2.48
Quick Ration/a
Debt / Equity0.15
Debt / EBITDA0.61
Debt / FCF-0.71
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)6.52%
Return on Assets (ROA)4.86%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employeen/a
Employee Countn/a
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$2.50M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+110.35%
50-Day Moving Average$24.90
200-Day Moving Average$16.92
Relative Strength Index (RSI)76.92
Average Volume (20 Days)780,204

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$94.20M
Operating Income$8.90M
Pretax Income$7.60M
Net Income$5.10M
EBITDA$19.30M
EBIT$9.10M
Earnings Per Share$0.11

Balance Sheet

Cash & Cash Equivalents$65.60M
Total Debt$11.71M
Net Cash$53.89M
Net Cash Per Sharen/a
Equity (Book Value)$78.21M
Book Value Per Sharen/a
Working Capital$19.38M

Cash Flow

Operating Cash Flow$22.70M
Capital Expendituresn/a
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$16.60M
FCF Per Sharen/a

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield0.44%
FCF Yieldn/a

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$1.65
Lynch Upside-93.40%
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a